Skip to content
Sign in

TRAX · NASDAQ

First Tracks Biotherapeutics (TRAX) Stock Price & Fundamentals

$699.06−0.17%−$1.21End-of-day price as of Oct 9, 2026

First Tracks Biotherapeutics (TRAX) closed at $699.06 on Oct 9, 2026, down 0.17% from the previous close of $700.27.

Share price, past year

1Y −12.83%

52-week range $699.06 – $833.98. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$699.06
Sep 30, 2026$730.04
Aug 31, 2026$737.80
Jul 31, 2026$747.25
Jun 30, 2026$811.83
May 29, 2026$783.38
Apr 30, 2026$832.76
Mar 31, 2026$820.87
Feb 27, 2026$796.03
Jan 30, 2026$778.62
Dec 31, 2025$739.55
Nov 28, 2025$782.07
Oct 31, 2025$798.33

Key statistics

52-week range
$699.06 – $833.98

Financials

First Tracks Biotherapeutics's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.

Company profile

Name
First Tracks Biotherapeutics, Inc.
Ticker
TRAX
Exchange
NASDAQ
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
10770 Wateridge Circle, Suite 210, San Diego, CA 92121
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0002091349

Recent SEC filings

Frequently asked questions

What is First Tracks Biotherapeutics's stock price?

First Tracks Biotherapeutics (TRAX) closed at $699.06 on Oct 9, 2026, down 0.17% from the previous close of $700.27.

Sources and methodology

Fundamentals come from First Tracks Biotherapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures